Here are some more items I've collected over the past few months that don't justify a separate post but are still of interest. Click on the link to see the study.
Users of DPP-4 Inhibitors (i.e. Januvia and Onglyza) report far more infections than metformin users, especially respiratory infections which were twelve times more likely. This is not surprising, DPP-4 plays a significant role in the
Diabetes Update
No comments:
Post a Comment